News

Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development

Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology

Nutriband Inc Joins Webull Corporate Communications Service Platform

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

Nutriband Inc. Commences Trading on Upstream Under NTRB

Nutriband Inc. Will Be the First Company to Dual List on Upstream

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

Get in touch

To find out more, or to enquire about our partnership options, please contact our team who can help find the right solution for your business.